this study. HIV-related retinopathy is seen in up to 50% of patients with AIDS in the developed countries,6 but in this study and others in Africa7 it was less common. This may be because it is seen more commonly with lower CD4+ counts.6
Neuro-ophthalmic manifestations of cerebral disease were a common finding, reflecting the prevalence of cerebral and meningeal infection in HIV in Africa. In contrast no patients had ophthalmic findings consistent with ophthalmic mycobacterial infection, despite the high prevalence of pulmonary tuberculosis.
No cases of cytomegalovirus (CMV) retinitis were seen: it appears to be a rare manifestation of HIV in Africa despite widespread prevalence of CMV in the African population.s This would seem to be because many African patients with HIV are dying from diseases such as tuberculosis and bacterial sepsis before CD4+ counts fall to the low levels « 100/ J.11) associated with CMV retinitis in the developed world.9 One recent West African study found a mean CD4+ cell count of 466/J.11 in patients with AIDS.lO There were not the means to measure CD4 counts at KCMC; interestingly, and in contrast, in a study from the Ivory Coast patients with HIV were profoundly immunosuppressed, 39% having CD4+ counts less than 50/J.1l, but ophthalmic disease was not reportedY This has led to speculation that early death may not completely explain the differences in CMV retinitis infection seen; however, it may be that once CD4+ counts become less than 50/ J.1l, when the relative risk of CMV retinitis in HIV is multiplied threefold,12 African patients with AIDS succumb very quickly to acute infections, and CMV retinitis is not seen.
None of the patients seen at KCMC had access to antiretroviral treatment: availability throughout Africa is extremely limited, which together with the reduced ability to adequately diagnose and treat opportunistic infections through financial constraint, are reasons for death before severe immunosuppression. The case of endophthalmitis which we report is most unusual, because we were unable to identify any predisposing immunological abnormality in our 5-year-old patient despite comprehensive investigation. 
